Pharmacokinetics and results of dose escalation inCis-platin hyperthermic isolation limb perfusion
- 1 May 1994
- journal article
- clinical trial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 1 (3) , 236-243
- https://doi.org/10.1007/bf02303529
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase I-II trial of hyperthermic isolated limb perfusion with cisplatin in the treatment of high risk malignant melanoma of the extremitiesMelanoma Research, 1991
- Improved survival of patients with stage II melanoma of the extremity using hyperthermic isolation perfusion with 1‐phenylalanine mustardJournal of Surgical Oncology, 1987
- Improved survival rates of patients with acral lentiginous melanoma treated with hyperthermic isolation perfusion, wide excision, and regional lymphadenectomyThe American Journal of Surgery, 1986
- Toxicity and complications of vascular isolation and hyperthermic perfusion with lmidazole carboxamide (DTIC) in melanomaCancer, 1986
- A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant MelanomaAnnals of Surgery, 1984
- Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studiesCancer, 1983
- The Treatment of Stage I Melanoma of the Extremities with Regional Hyperthermic Isolation PerfusionAnnals of Surgery, 1982
- Chemotherapy of Melanoma of the Extremities by PerfusionAnnals of Surgery, 1972
- Chemotherapy of CancerAnnals of Surgery, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958